News
Zacks Investment Research on MSN8h
Vertex (VERX) Q2 Earnings and Revenues Surpass EstimatesVertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.15 per share a year ago. These figures are ...
Clinical Trials Arena on MSN11h
Vertex’s Journavx successor culled after falling short in Phase II trialTopline results reveal that VX-993 did not meet its primary endpoints, meaning Vertex will discontinue its development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback